IP Library Granted Patent US 8,426,203
Granted Patent B2
US 8,426,203 · App. 13/427,548 · Granted Apr 23, 2013

Culture medium containing gamma-aminobutyric acid, pipecolic acid or lithium for the maintenance of stem cells in an undifferentiated state

Inventors: James A. Thomson (Madison, WI); Tenneille Ludwig (Fitchburg, WI)
Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,203
App. No.
13/427,548
Granted
Apr 23, 2013
Kind
B2
Abstract

Previous methods for culturing primate pluripotent stem cells have required either fibroblast feeder cells or a medium which was exposed to fibroblast feeder cells to maintain the stem cells in an undifferentiated state. It has now been found that high levels of fibroblast growth factor in a medium together with at least one of gamma aminobutyric acid, pipecolic acid, and lithium, enables pluripotent stem cells to remain undifferentiated indefinitely through multiple passages, even without feeder cells or conditioned medium. Without beta-mercaptoethanol, the medium improves cloning efficiency. Also, a matrix of human proteins can be used to culture the undifferentiated cells without exposing the cells to animal products. Further disclosed are new primate pluripotent cell lines made using the defined culture conditions, including the medium and the matrix. Such new cell lines will have never been exposed to animal cells, animal products, feeder cells or conditioned medium.

Claims (5)

1. A medium comprising salts, vitamins, amino acids, glucose, albumin, minerals, lipids, a transferrin or a transferrin substitute, insulin or an insulin substitute, a fibroblast growth factor, and at least one member selected from gamma-aminobutyric acid, pipecolic acid and lithium, and optionally transforming growth factor beta, in sufficient amounts to maintain stem cells grown in the medium in an undifferentiated state through multiple culture passages.

2. A medium comprising salts, vitamins, amino acids, glucose, albumin, minerals, lipids, a transferrin or a transferrin substitute, insulin or an insulin substitute, a fibroblast growth factor, and at least two members selected from gamma-aminobutyric acid, pipecolic acid and lithium, and optionally transforming growth factor beta, in sufficient amounts to maintain stem cells grown in the medium in an undifferentiated state through multiple culture passages.

3. A medium comprising salts, vitamins, amino acids, glucose, albumin, minerals, lipids, a transferrin or a transferrin substitute, insulin or an insulin substitute, a fibroblast growth factor, gamma-aminobutyric acid, pipecolic acid and lithium, and optionally transforming growth factor beta, in sufficient amounts to maintain stem cells grown in the medium in an undifferentiated state through multiple culture passages.

4. The medium of claim 1 , 2 or 3 , wherein the insulin and transferrin are recombinant proteins.

5. The medium of claim 1 , 2 or 3 , wherein the stem cells are primate pluripotent stem cells.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 15, 2018
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045603/0584 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2013
From: THOMSON, JAMES; LUDWIG, TENNEILLE
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 030366/0950 →
Continuity (8)
Continuation 12754574 · Apr 5, 2010
Continuation In Part 12209325 · Sep 12, 2008
Continuation 11221457 · Sep 8, 2005
Continuation In Part 12242085 · Sep 30, 2008
Continuation 11221516 · Sep 8, 2005
Provisional Application 60608040 · Sep 8, 2004
Provisional Application 60695100 · Jun 29, 2005
Related Publication 20120178161A1 · Jul 12, 2012